Abstract
We conducted a retrospective study in patients with non-small cell lung cancer (NSCLC) who underwent curative lung resection to seek for better lung function parameters associated with long-term survival after lung resection. From January 2006 to December 2008, 470 patients who underwent lung resection with a postoperative diagnosis of NSCLC were studied. Median survival time was 60 months. Patients with pulmonary function values <80 % of predicted were defined as lung function impairment. Patients with impaired vital capacity, maximal voluntary ventilation, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) or diffusion capacity for carbon monoxide (DLCO) had significant shorter overall survival time (P = 0.024; P = 0.026; P < 0.001; P = 0.027; P = 0.007). In univariate analysis, VC, FVC, FEV1 and DLCO were found to have significant effect on overall survival. In multivariate analysis, FVC (HR, 2.029; 95 % CI 1.126–3.659; P = 0.019) was found to be an independent prognostic predictor of long-term overall survival. For cancer-specific survival, FVC (HR 2.404; 95 % CI 1.300–4.445; P = 0.005) was also found to be an independent prognostic predictor in multivariable analysis. Preoperative FVC, rather than FEV1 or DLCO, is an independent prognostic predictor for long-term survival. FVC is not only an indicator of lung function but also of great value for surgeons to predict survival after lung resection.
Similar content being viewed by others
Abbreviations
- NSCLC:
-
Non-small cell lung cancer
- VC:
-
Vital capacity
- MVV:
-
Maximal voluntary ventilation
- FVC:
-
Forced vital capacity
- FEV1:
-
Forced expiratory volume in one second
- PEF:
-
Peak expiratory flow
- MMEF:
-
Maximum mid-expiratory flow
- DLCO:
-
Diffusion capacity for carbon monoxide
- RV/TLC:
-
Residual volume/total lung capacity
- MST:
-
Median survival time
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90 PubMed PMID: 21296855. Epub 2011/02/08. eng.
Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T. Survival for clinical stage I lung cancer not surgically treated. Comparison between screen-detected and symptom-detected cases. The Japanese Lung Cancer Screening Research Group. Cancer. 1992;69(3):685–92 PubMed PMID: 1730119. Epub 1992/02/01. eng.
Boushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59(4):383–91.
Wernly JA, DeMeester TR, Kirchner PT, Myerowitz PD, Oxford DE, Golomb HM. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1980;80(4):535.
Bousamra M II, Presberg KW, Chammas JH, Tweddell JS, Winton BL, Bielefeld MR, et al. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996;62(4):968–75.
Win T, Jackson A, Sharples L, Groves A, Wells F, Ritchie A, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J. 2005;25(4):594–9.
Lee JH, Song EM, Sim YS, Ryu YJ, Chang JH. Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(2):305.
Ferguson MK, Dignam JJ, Siddique J, Vigneswaran WT, Celauro AD. Diffusing capacity predicts long-term survival after lung resection for cancer. Eur J Cardiothorac Surg. 2012;41(5):e81–6.
Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovascu Surg. 1999;117(3):581–7.
Gray L, Hart CL, Smith GD, Batty GD. What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland. Eur J Cardiovascu Prev Rehabil. 2010;17(1):106–12.
Roberts MH, Mapel DW. Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults. Am J Epidemiol. 2012;176(2):127–34.
Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol. 2009;100(8):703–7.
Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68.
Salzman SH. Which pulmonary function tests best differentiate between COPD phenotypes? Respir Care. 2012;57(1):50–60.
Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37(1):95–102.
Korst RJ, Ginsberg RJ, Ailawadi M, Bains MS, Downey RJ, Rusch VW, et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg. 1998;66(3):898–902.
Baldi S, Ruffini E, Harari S, Roviaro GC, Nosotti M, Bellaviti N, et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg. 2005;130(6):1616.
Vaughan P, Oey I, Nakas A, Martin-Ucar A, Edwards J, Waller D. Is there a role for therapeutic lobectomy for emphysema? Eur J Cardiothorac Surg. 2007;31(3):486–90.
Lee H, Le H, Lee B, Lopez V, Wong N. Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality. Eur Respir J. 2010;36(5):1002–6.
Burney P, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.
Anderson H, Vallance P, Bland J, Nohl F, Ebrahim S. Prospective study of mortality associated with chronic lung disease and smoking in Papua New Guinea. Int J Epidemiol. 1988;17(1):56–61.
Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults. JAMA. 1998;279(8):585–92.
Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol. 1990;43(9):867–73.
Sorlie PD, Kannel WB, O’Connor G. Mortality associated with respiratory function and symptoms in advanced age: the Framingham study. Am J Respir Crit Care Med. 1989;140(2):379–84.
Barker D, Bull A, Osmond C, Simmonds S. Fetal and placental size and risk of hypertension in adult life. Br Med J. 1990;301(6746):259–62.
Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ (Clinical research ed). 1991;303(6804):671–5 PubMed PMID: 1912913. Pubmed Central PMCID: PMC1670943. Epub 1991/09/21. eng.
Acknowledgments
The work was supported by Provincial Science and Technology Development Planning of Shandong (2011GGH21819) and Provincial Science and Technology Development Planning of Shandong (2012G0021836).
Conflict of interest
None of the authors declared Conflicts of Interest Statement of the article titled “Forced vital capacity is an independent prognostic predictor of long-term survival for curative resected NSCLC”.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Xi Guo and Hongxin Cao have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Guo, X., Cao, H., Xu, J. et al. Forced vital capacity predicts long-term survival for curative-resected NSCLC. Med Oncol 31, 146 (2014). https://doi.org/10.1007/s12032-014-0146-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0146-x